Paris, 12th November 2018: In an all-time record year for FDA approvals (48 so far in 2018), Pharmapack Europe reports that innovation is also … Keep Reading
Novo Nordisk’s Chief Science Officer Mads Krogsgaard Thomsen explains about diabetes and the discovery of insulin, the development of insulin and the differences of human insulin, modern insulin and the next generation insulin.
4 symposiums on Oncology, General Biologics, Immunology and Cardiology at 6th annual BioPharma Asia Convention 2013. Research on Oncology, Cardiology, Immunology and
[column]A study of older patients with advanced head and neck cancers has found that where they were treated significantly influenced their survival.